This compound is a protected dipeptide consisting of valine and citrulline, with a fluorenylmethoxycarbonyl (Fmoc) protecting group. It is used as an intermediate in peptide synthesis, particularly in the preparation of conjugates for research applications.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 159858-21-6
Fmoc-Val-Lys(Boc)-OH
research reagent for peptide synthesis
Fmoc-Val-Cit-PAB
research reagent for conjugation
(2S)-2-{[(tert-butoxy)carbonyl]amino}-5-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)pentanoic acid
peptide synthesis intermediate
(23S,50S)-50-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-23-(tert-butoxycarbonyl)-2,2-dimethyl-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
peptide synthesis intermediate
Boc-His(Trt)-Aib-OH
peptide synthesis intermediate
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[1-(2-hydroxy-4,4-dimethyl-6-oxocyclohexen-1-yl)ethylideneamino]butanoic acid
peptide synthesis intermediate
Dxd
exatecan derivative for antibody-drug conjugate
(R)-3-((tert-Butoxycarbonyl)amino)butanoic acid
Pharmaceutical intermediate for peptide synthesis
(2S)-5-(carbamoylamino)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylbutanoyl]amino]pentanoic acid
ZJLNQOIFTYLCHC-VXKWHMMOSA-N
CC(C)[C@@H](C(=O)N[C@@H](CCCNC(=O)N)C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13